Influence of selenium supplements on the post-traumatic alterations of the thyroid axis: a placebo-controlled trial

Related Experiment Videos

M M Berger1, M J Reymond, A Shenkin

  • 1Soins Intensifs de Chirurgie, CHUV, Lausanne, Switzerland. Mette.Berger@chuv.hospvd.ch

Insights

Early selenium supplementation normalized plasma selenium levels in critically ill trauma patients. This intervention showed modest improvements in thyroid hormone metabolism, with faster normalization of T4 and reverse T3.

Area of Science:

  • Critical Care Medicine
  • Nutritional Biochemistry
  • Endocrinology

Background:

  • Post-traumatic period is characterized by low plasma selenium and negative selenium balance.
  • Thyroid hormone metabolism is significantly altered in critically ill trauma patients.
  • Early nutritional support may influence recovery and metabolic derangements.

Purpose of the Study:

  • To investigate the effect of early selenium supplementation on post-traumatic thyroid hormone metabolism.
  • To determine if selenium levels influence thyroid hormone normalization after severe injury.
  • To assess the impact of combined alpha-tocopherol and zinc with selenium.

Main Methods:

  • Prospective, placebo-controlled randomized supplementation trial in a surgical ICU.
  • Critically ill trauma patients (n=31) with severe multiple injuries received selenium or placebo for 5 days.
  • Measurements included plasma selenium, alpha-tocopherol, zinc, and thyroid hormones (T4, T3, reverse T3) over 20 days.

Main Results:

  • Selenium supplementation normalized plasma selenium levels by day 1.
  • Patients receiving selenium showed faster and greater increases in total T4 and T3 post-injury.
  • A significant reduction in reverse T3 levels was observed between day 0 and day 2 in the selenium group.

Conclusions:

  • Early selenium supplementation effectively increased circulating selenium levels in trauma patients.
  • Selenium supplementation was associated with modest, beneficial changes in thyroid hormone profiles.
  • Co-administration of alpha-tocopherol and zinc did not provide additional benefits to thyroid hormone normalization.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...